XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   71,047      
Beginning balance at Dec. 31, 2022 $ 309,965 $ 71 $ 635,668 $ (2,688) $ (323,086)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity component from partial repurchase of 2023 convertible senior notes (in shares)   2      
Issuance of common stock upon partial conversion of the 2023 convertible senior notes 0   0    
Settlement at maturity of the outstanding capped calls and retirement of common stock related to the 2023 convertible senior notes (in shares)   (371)      
Settlement at maturity of the outstanding capped calls and retirement of common stock related to the 2023 convertible senior notes 74,453   74,453    
Issuance of common stock upon exercise of stock options (in shares)   379      
Issuance of common stock upon exercise of stock options 6,981   6,981    
Issuance of common stock upon vesting of restricted stock units (in shares)   919      
Issuance of common stock upon vesting of restricted stock units 0 $ 1 (1)    
Issuance of common stock under ESPP (in shares)   204      
Issuance of common stock under ESPP 9,444   9,444    
Stock-based compensation 105,652   105,652    
Other comprehensive income (loss) 1,291     1,291  
Net loss (48,987)       (48,987)
Ending balance (in shares) at Jun. 30, 2023   72,180      
Ending balance at Jun. 30, 2023 458,799 $ 72 832,197 (1,397) (372,073)
Beginning balance (in shares) at Mar. 31, 2023   71,544      
Beginning balance at Mar. 31, 2023 339,086 $ 72 690,309 (961) (350,334)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Equity component from partial repurchase of 2023 convertible senior notes (in shares)   2      
Issuance of common stock upon partial conversion of the 2023 convertible senior notes 0   0    
Settlement at maturity of the outstanding capped calls and retirement of common stock related to the 2023 convertible senior notes (in shares)   (371)      
Settlement at maturity of the outstanding capped calls and retirement of common stock related to the 2023 convertible senior notes 74,453   74,453    
Issuance of common stock upon exercise of stock options (in shares)   240      
Issuance of common stock upon exercise of stock options 3,856   3,856    
Issuance of common stock upon vesting of restricted stock units (in shares)   561      
Issuance of common stock upon vesting of restricted stock units (1)   (1)    
Issuance of common stock under ESPP (in shares)   204      
Issuance of common stock under ESPP 9,444   9,444    
Stock-based compensation 54,136   54,136    
Other comprehensive income (loss) (436)     (436)  
Net loss (21,739)       (21,739)
Ending balance (in shares) at Jun. 30, 2023   72,180      
Ending balance at Jun. 30, 2023 458,799 $ 72 832,197 (1,397) (372,073)
Beginning balance (in shares) at Dec. 31, 2023   73,317      
Beginning balance at Dec. 31, 2023 538,085 $ 73 942,280 582 (404,850)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of new capped calls associated with the 2029 convertible senior notes (93,438)   (93,438)    
Settlement at maturity of the outstanding capped calls and retirement of common stock related to the 2023 convertible senior notes 539   539    
Issuance of common stock upon exercise of stock options (in shares)   15      
Issuance of common stock upon exercise of stock options 397   397    
Issuance of common stock upon vesting of restricted stock units (in shares)   1,178      
Issuance of common stock upon vesting of restricted stock units 2 $ 2      
Issuance of common stock under ESPP (in shares)   209      
Issuance of common stock under ESPP 9,522   9,522    
Stock-based compensation 91,748   91,748    
Other comprehensive income (loss) (1,084)     (1,084)  
Net loss (19,893)       (19,893)
Ending balance (in shares) at Jun. 30, 2024   74,719      
Ending balance at Jun. 30, 2024 525,878 $ 75 951,048 (502) (424,743)
Beginning balance (in shares) at Mar. 31, 2024   73,849      
Beginning balance at Mar. 31, 2024 483,598 $ 74 895,754 (303) (411,927)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   1      
Issuance of common stock upon exercise of stock options 11   11    
Issuance of common stock upon vesting of restricted stock units (in shares)   660      
Issuance of common stock upon vesting of restricted stock units 1 $ 1      
Issuance of common stock under ESPP (in shares)   209      
Issuance of common stock under ESPP 9,522   9,522    
Stock-based compensation 45,761   45,761    
Other comprehensive income (loss) (199)     (199)  
Net loss (12,816)       (12,816)
Ending balance (in shares) at Jun. 30, 2024   74,719      
Ending balance at Jun. 30, 2024 $ 525,878 $ 75 $ 951,048 $ (502) $ (424,743)